Supporting the Commercialisation Journey
AHNTI attracts 200+ startups and scale-ups addressing key unmet needs with well differentiated, makeable, and scalable solutions. Covering...
- Biopharma, nutrition, diagnostics, technology
- Animals small and large
- All stages of development – from seed to growth capital
- Key disease areas - prediction, prevention, detection, treatment
- Projected revenues - $20m, $50m, $100m, $200m+
Founders are actively looking for partners across CROs, CDMO, Regulatory, IP and Legal, Deal Management, Distribution, Communications, Sales & Marketing and Consultancy.
Ecosystem Wide Relationships
850+ leaders and over 2,000 pre-scheduled 1-to-1 meetings allow you to not only connect with Founders and support them along their commercialisation journey, but also build relationships and explore collaborations and partnerships throughout the entire ecosystem represented at AHNTI.